Verification of therapeutic effects and prognosis by mesenchymal stem cell therapy in regenerative medicine and neuro rehabilitation for stroke patients

Verification of therapeutic effects and prognosis by mesenchymal stem cell therapy in regenerative medicine and neuro rehabilitation for stroke patients - Verification of therapeutic effects and prognosis by mesenchymal stem cell therapy in regenerative medicine and neuro rehabilitation for stroke patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000050323

Enrollment

Registered

2023-02-13

Start date

2023-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

stroke patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) stroke patient (ischemic) 2) motor paralysis remains in upper limb or lower limb 3) to receive mesenchymal stem cell therapy 4) informed consent is obtained

Exclusion criteria

Exclusion criteria: 1) no informed consent is obtained

Design outcomes

Primary

Measure	Time frame
Fugl-Meyer Assessment (upper extremity) Fugl-Meyer Assessment (lower extremity) Bells test Timed up & go test 5m walk test Modified Rankin Scale Modified Ashworth Scale	—

Countries

Japan

Contacts

Public ContactMasaki Tamura

Okayama Healthcare Professional University Department of Physical Therapy, Faculty of Health Sciences

tamura@opu.ac.jp086-233-8020

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026